Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 14/20 | 0.73 |
| ▸ | MAOA | P21397 | 2/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | HASPIN | Q8TF76 | 4/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.54 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27939721 | 0.90 | DYRK1A (0.59) | DYRK1AMAOAACHEHASPINHTR2A | |
| SCHEMBL27917535 | 0.89 | DYRK1A (0.76) | DYRK1AMAOAHASPINHTR2AHTR2C | |
| SCHEMBL27939719 | 0.86 | DYRK1A (0.75) | DYRK1AMAOAACHEHASPINHTR2A | |
| SCHEMBL27917524 | 0.85 | DYRK1A (0.77) | DYRK1AMAOAACHEHASPINHTR2A | |
| SCHEMBL668477 | 0.85 | DYRK1A (1.00) | DYRK1AMAOAACHEHASPINHTR2A | |
| Benzene SCHEMBL27939712 | 0.83 | DYRK1A (0.73) | DYRK1AMAOAACHEHASPINHTR2A | |
| SCHEMBL27939724 | 0.81 | DYRK1A (0.83) | DYRK1AMAOAACHEHASPINHTR2A | |
| SCHEMBL27921179 | 0.81 | DYRK1A (0.65) | DYRK1AMAOAACHEHASPINHTR2A | |
| Benzene SCHEMBL27921298 | 0.79 | DYRK1A (0.58) | DYRK1AMAOAACHEHASPINHTR2A | |
| SCHEMBL14915781 | 0.79 | DYRK1A (0.61) | DYRK1AMAOAACHEHASPINHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101429198-B | Banisterine derivant and uses thereof | XINJIANG HUASHIDAN MEDICAMENTS RES CO LTD | 2013-10-23 | — | — | CN | disclosed |